Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Medications Research Articles
Popular Medications Research Articles
Highly Recommended Medications Research Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Peptide Used to Combat Alzheimer’s Found to Be Powerful Insulin Regulator
The results of the study considerably advance the notion that the brain is far more associated with diabetic processes than was believed even a few years ago.
Humanin (HN) is a mitochondrial peptide* that in some research has shown the ability to protect against the death of neurons, the devastating consequence of diseases like Alzheimer's. According to the leader of a research team at the Albert Einstein College of Medicine at Yeshiva University in the Bronx, however, it also significantly improves the insulin sensitivity of diabetic rats and sharply drops their glucose levels.
In short, says Dr. Nir Barzilai, the Ingeborg and Ira Leon Rennert Chair of Aging Research and Director of the Institute for Aging Research at the college, HN is the most powerful insulin metabolism regulator his team has ever seen.
Dr. Barzilai's research into HN is an outgrowth of his study of longevity among several hundred Ashkenazi Jews, aged 95 to 112, and their offspring. In his study, he found that although production of HN decreases in people as they age, it decreased less in the Azhkenazi group. Their children also had high levels of HN, a genetic endowment.
The ultimate controllable effects of HN on insulin metabolism, says Dr. Barzilai, will probably be intertwined with two genes: one for insulin-like growth factor (IGF-1) and the other for insulin-like growth factor binding protein-3 (IGFBP-3). Dr. Barzilai had previously found that some of the oldest of his Ashkenazi patients had a mutation in the IGF-1 gene that has been shown in other life forms, including mammals, to prolong life span.
In the current study involving HN, his team found that IGFBP-3 inhibited HN's effect on insulin action and that when the gene was inhibited, HN's potency increased.
All of this points to a possible new drug therapy, obviously several years down the road as scientists cautiously move from laboratory experiments to experiments with human test subjects. In the meantime, the results of the study considerably advance the notion that the brain is far more associated with diabetic processes than was believed even a few years ago.
* A peptide is a molecule consisting of two or more amino acids. They are like proteins, which are also extended chains of amino acids, but smaller.
Categories: Diabetes, Diabetes, Insulin, Insulin Resistance, Medications Research, Research, Type 1 Issues, Type 2 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
This is so heartending. It may not make it in "my time" but soon, in a research sense. Thanks. It helps to keep me on track. What I REALLY want is a clinical trial for overweight type ONEs, though.
In regards to these peptides, what it their source? Are they in foods and do we have access to them now?
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...